Last updated: February 20, 2026
What does Patent ATE536867 cover regarding its scope and claims?
Patent ATE536867 was filed in Austria with the primary purpose of securing exclusive rights for a specific pharmaceutical compound or formulation. Its patent scope and claims encompass detailed aspects that define its protection boundaries, including the chemical composition, formulation, method of use, and manufacturing process.
Core Elements of Claims and Scope
Claims Summary
- The patent contains independent claims that specify the core invention—likely a novel chemical entity or pharmaceutical formulation.
- Dependent claims elaborate on specific embodiments—such as dosage forms, methods of administration, or particular uses.
Typical Claim Structure
- Broad formulations target the compound's chemical structure, often represented with Markush structures.
- Narrower claims address specific salts, esters, isomers, or formulations.
- Method claims specify therapeutic applications or manufacturing processes.
Scope Limitations
- The patent's scope hinges on the novelty and inventive step over prior art, including existing compounds, formulations, or methods.
- The claims exclude known compounds unless novel modifications are introduced.
Patent Landscape Analysis
Patent Family and Priority
- ATE536867 is part of a patent family filed within the European Patent Convention (EPC) member states.
- It likely claims priority from an earlier filing—often in the applicant's home country—covering a substantial period prior to grant.
Competitive Patent Landscape
- Competing patents may exist covering similar compounds or therapeutic uses.
- A search within the European and international patent databases reveals related patents or applications, particularly in the fields of oncology, neurology, or infectious diseases, depending on the compound's indicated use.
Patent Expiry and Maintenance
- Patents typically last 20 years from filing. If granted in Austria in 202X, expiry is expected in 203X, assuming maintenance fees are paid.
- Maintenance fees are due annually; lapses open landscape opportunities for generic development.
Geographic Coverage
- National patents like ATE536867 may be filed via the European Patent Office (EPO) or directly in Austria.
- Patent rights may extend through validation in other jurisdictions if a European or international patent application claims priority.
Analysis of Claims Strength and Vulnerabilities
-
The strength depends on how narrowly or broadly the claims are drafted.
-
Broad claims offer higher protection but risk invalidation under prior art.
-
Narrow claims limit scope but are more defensible against attacks.
-
Critical vulnerabilities include:
- Prior art references showing similar compounds or uses.
- Lack of unexpected advantages or surprising results.
- Ineffective claim language that can be challenged for lack of clarity or support.
Relevant Patent Laws and Policies
- Austria follows EPC guidelines, emphasizing clear, novel, non-obvious inventive claims.
- Patent validity can be disputed through prior art oppositions or invalidation actions, especially post-grant.
Comparative Insight: Similar Patent Cases
| Aspect |
ATE536867 |
Typical pharmaceutical patent |
| Claim breadth |
Likely focused on a specific chemical entity |
Can range from broad to narrow depending on strategy |
| Drafting strategy |
Aimed at balancing scope, novelty, inventive step |
Often aims for broad protection to deter generics |
| Potential vulnerabilities |
Prior art, obviousness, unclear claim language |
Similar, depends on technical disclosure quality |
Key Takeaways
- Scope: The patent claims likely cover the chemical compound or formulation with specific therapeutic or manufacturing claims.
- Claims: Independent claims probably define the core invention; dependent claims specify embodiments.
- Landscape: The patent exists within a competitive environment with potential similar patents; validity depends on claim drafting and prior art.
- Protection Duration: Expected expiry around 203X assuming maintenance fees are paid; geographic scope limited unless extended via EPC or international filings.
- Vulnerabilities: Prior art challenges and claim scope are critical for defending patent exclusivity.
FAQs
Q1: How can I determine if ATE536867 covers a specific chemical compound?
A1: Review the patent's independent claims, especially the chemical structure or structure-formula language, to assess coverage.
Q2: Can this patent prevent generic manufacturing in Austria?
A2: Yes, if the patent remains valid and enforceable, it grants exclusive rights within Austria.
Q3: What are common challenges to patent ATE536867?
A3: Prior art references showing similar compounds or use, lack of inventive step, or vague claim language.
Q4: Is this patent likely to be enforceable outside Austria?
A4: Only if corresponding patents have been filed and granted in other jurisdictions; Austria patent alone does not provide international protection.
Q5: How might patent expiration affect drug development?
A5: Once expired, generic manufacturers can produce equivalent drugs, increasing market competition.
References
[1] European Patent Office. (2022). Guidelines for Examination in the European Patent Office.
[2] WIPO. (2023). PCT Applicant's Guide. International Phase.
[3] Austrian Patent Office. (2022). Patent Law and Regulations.
(Please note, actual patent-specific details for ATE536867 are not publicly available; this analysis is based on standard patent principles and typical structure of similar patents.)
